BizCom Japan, Inc. and Fusion Antibodies Ltd have agreed a Distribution and Marketing Agreement for services and products of Antibody Sequencing and Humanization in Japan.
BizCom Japan, Inc., a privately-held Japan-based trading and consulting company, and Fusion Antibodies Ltd, a privately-held, UK-based biotech company, announced today that they have entered into a distribution and marketing agreement.
BizCom Japan Inc. has been engaged in sales and marketing of research reagents, services and equipment to the life science research market in Japan and consulting for innovative biotech companies in Japan as well as other countries, and has extensive experience in establishing various types of alliances with Japanese companies and public institutions. BizCom Japan, Inc. will use this experience and its sales and marketing expertise to exclusively market services and products of Fusion Antibodies in Japan.
More information can be found in our most recent press release here.